<DOC>
	<DOCNO>NCT01452750</DOCNO>
	<brief_summary>The purpose study evaluate efficacy TAK-438 , daily ( QD ) , compare AG-1749 ( Lansoprazole ) patient history gastric duodenal ulcer require long-term therapy non-steroidal anti-Inflammatory drug ( NSAID ) .</brief_summary>
	<brief_title>Efficacy Safety TAK-438 Prevention Recurrent Gastric Duodenal Ulcers During Therapy Non-steroidal Anti-inflammatory Drug ( NSAID )</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>1 . Participants require continuous NSAID therapy treatment period study drug 2 . Participants history ulcer stomach duodenum , endoscopically confirm 3 . Outpatient ( include inpatient examination ) 1 . Participants schedule change type dosage regimen NSAID 2 . Participants ulcer bleed stomach duodenum , endoscopically confirm 3 . Participants small intestine bleeding , large intestine bleeding , gastrointestinal bleed unknown etiology 4 . Participants history surgery affect gastric acid secretion ( e.g. , resection upper gastrointestinal tract , vagotomy ) schedule undergo surgery 5 . Participants previous current history ZollingerEllison syndrome , gastric acid hypersecretion disorder 6 . Participants previous current history aspirininduced asthma</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>